FDA clears Perspectum's liver cancer decision tool

By AuntMinnie.com staff writers

January 28, 2021 -- The U.S. Food and Drug Administration (FDA) has cleared image analysis software developer Perspectum's Hepatica surgical decision-support tool for liver cancer.

Hepatica is a precision oncology decision-support tool for liver cancer
Hepatica is a precision oncology decision-support tool for liver cancer. Image courtesy of Perspectum.

Surgery is a key liver cancer treatment option, and accurate presurgical staging is crucial, according to Perspectum. Hepatica uses quantitative, multiparametric MRI data to produce a liver health assessment that allows clinicians to make more informed decisions before surgery and thus improve postsurgery outcomes, the company said.


Copyright © 2021 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: